SOPs for Drug Discovery

The purpose of this Standard Operating Procedure (SOP) is to describe the process for validating assay methods used in drug discovery. Assay validation is a critical step to ensure the reliability, reproducibility, and robustness of assays employed in screening potential drug candidates. This SOP ensures that assays meet required performance standards, providing high-quality data for further optimization and decision-making in drug discovery.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for developing assays for target screening in drug discovery. Assay development is crucial for evaluating the interaction between drug candidates and biological targets, such as enzymes, receptors, or other molecular entities. This SOP ensures that assays are developed efficiently, with high sensitivity and reproducibility, to facilitate the identification of potential drug candidates for further optimization and development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process for isolating natural products from plant, microbial, or marine sources for use in drug discovery. Natural products have long been a source of novel compounds with therapeutic potential. This SOP ensures that the isolation process is conducted systematically, efficiently, and safely to identify bioactive natural products that may serve as lead candidates for drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of microbial screening for antimicrobial compounds in drug discovery. Microbial screening involves evaluating the antimicrobial activity of compounds against a wide range of microorganisms to identify potential drug candidates for the treatment of infections. This SOP ensures that microbial screening is conducted systematically, with proper controls and data analysis, to identify promising antimicrobial agents for further development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the proper handling, operation, and maintenance of high-throughput screening (HTS) equipment used in drug discovery. HTS is a technology that allows for the rapid testing of large numbers of compounds to identify potential drug candidates. This SOP ensures that HTS equipment is used safely and effectively to maximize the reliability of screening results, maintain equipment performance, and ensure compliance with safety and regulatory standards.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for applying omics data in target validation during drug discovery. Omics technologies, including genomics, proteomics, metabolomics, and transcriptomics, provide high-throughput data that can identify potential drug targets and validate their relevance in disease mechanisms. This SOP ensures that omics data are systematically integrated into the target validation process to enhance the discovery of novel therapeutic targets and improve drug development outcomes.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for assessing the drug-likeness parameters of compounds during the early stages of drug discovery. Drug-likeness refers to the chemical and pharmacological properties of a compound that are favorable for development as a drug candidate. This SOP ensures that drug-likeness is systematically evaluated using computational and experimental methods to select lead compounds with optimal drug-like characteristics.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the use of Artificial Intelligence (AI) and Machine Learning (ML) techniques in drug discovery. AI and ML are powerful computational tools that enable the identification of new drug candidates by predicting biological activity, optimizing chemical structures, and analyzing large-scale biological data. This SOP ensures that AI and ML technologies are applied systematically, efficiently, and ethically to enhance the drug discovery process, from target identification to lead optimization.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process for the synthesis of lead compounds in drug discovery. The synthesis of lead compounds is a crucial step in the drug development process, enabling the generation of compounds that can be tested for biological activity and optimized for therapeutic use. This SOP ensures that lead compounds are synthesized efficiently, safely, and in compliance with regulatory guidelines, enabling their use in further drug discovery efforts.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process for predicting the toxicity of lead compounds during the lead optimization phase of drug discovery. Toxicity prediction is a crucial step in identifying and mitigating potential adverse effects early in the drug development process. This SOP ensures that toxicity prediction is performed systematically using computational models, in silico tools, and experimental data to inform the optimization of lead candidates.
Click to read the full article.